- Home
- NEGG vs STRO Comparison
NEGG vs STRO Comparison
Compare NEGG & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- STRO
- Stock Information
- Founded
- NEGG 2001
- STRO 2003
- Country
- NEGG United States
- STRO United States
- Employees
- NEGG N/A
- STRO N/A
- Industry
- NEGG Other Specialty Stores
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NEGG Consumer Discretionary
- STRO Health Care
- Exchange
- NEGG Nasdaq
- STRO Nasdaq
- Market Cap
- NEGG 180.8M
- STRO 172.8M
- IPO Year
- NEGG 2010
- STRO 2018
- Fundamental
- Price
- NEGG $0.45
- STRO $1.93
- Analyst Decision
- NEGG
- STRO Strong Buy
- Analyst Count
- NEGG 0
- STRO 7
- Target Price
- NEGG N/A
- STRO $12.14
- AVG Volume (30 Days)
- NEGG 900.5K
- STRO 1.3M
- Earning Date
- NEGG 01-14-2025
- STRO 11-13-2024
- Dividend Yield
- NEGG N/A
- STRO N/A
- EPS Growth
- NEGG N/A
- STRO N/A
- EPS
- NEGG N/A
- STRO N/A
- Revenue
- NEGG $1,391,833,000.00
- STRO $160,955,000.00
- Revenue This Year
- NEGG $6.01
- STRO N/A
- Revenue Next Year
- NEGG N/A
- STRO N/A
- P/E Ratio
- NEGG N/A
- STRO N/A
- Revenue Growth
- NEGG N/A
- STRO 230.90
- 52 Week Low
- NEGG $0.39
- STRO $1.70
- 52 Week High
- NEGG $1.32
- STRO $6.13
- Technical
- Relative Strength Index (RSI)
- NEGG 37.38
- STRO 34.06
- Support Level
- NEGG $0.39
- STRO $1.80
- Resistance Level
- NEGG $0.48
- STRO $2.01
- Average True Range (ATR)
- NEGG 0.04
- STRO 0.16
- MACD
- NEGG -0.00
- STRO 0.02
- Stochastic Oscillator
- NEGG 26.52
- STRO 29.49
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.